US Food and Drug Administration (2004). Challenge and Opportunity on the Critical Path to New Medical Products, iv + 31 pp. Silver Spring, MD, USA: Food and Drug Administration.
3.
GunnM., VaudanoE., & GoldmanM. (2012). The rational use of animals in drug development: Contribution of the Innovative Medicines Initiative. ATLA40, 307–312.
4.
RowanA.N., & StratmanC.J. (1980). The Use of Alternatives in Drug Research, 190 pp. London & Basingstoke, UK: Macmillan.
5.
BallsM., RiddellR.J., & WordenA.N. (1983). Animals and Alternatives in Toxicity Testing, 550 pp. London, UK: Academic Press.
6.
BallsM., BridgesJ., & SoutheeJ. (1991). Animals and Alternatives in Toxicology, 390 pp. London, UK: Macmillan.
7.
BallsM. (2011). Modern alternative approaches to the problem of drug-induced liver injury. ATLA39, 103–107.
